Medicure (MCUJF) Cash from Financing Activities (2011 - 2026)

Medicure's Cash from Financing Activities history runs 14 years deep, the most recent figure standing at -$81671.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 31.67% year-over-year to -$81671.0; the TTM figure through Mar 2026 stood at -$316937.9 (down 15.12% YoY), while the FY2025 annual figure was -$297590.8, down 12.36% from the prior year.
• Cash from Financing Activities was -$81671.0 for Q1 2026 at Medicure, down from -$79596.6 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of -$52886.6 in Q4 2023 to a low of -$167917.4 in Q3 2022.
• Historically, Cash from Financing Activities has averaged -$76192.0 across 5 years, with a median of -$64085.6 in 2022.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities plunged 123.45% in 2022, then soared 67.13% in 2023.
• A 5-year view of Cash from Financing Activities shows it stood at -$167917.4 in 2022, then jumped by 68.5% to -$52886.6 in 2023, then slumped by 62.43% to -$85901.9 in 2024, then climbed by 7.34% to -$79596.6 in 2025, then fell by 2.61% to -$81671.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$81671.0 (Q1 2026), -$79596.6 (Q4 2025), and -$74116.8 (Q3 2025), per Business Quant data.